These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5684496)

  • 21. Enhancing effect of chemicals on production of hyperplastic liver nodules induced by n-2-fluorenylacetamide in hepatectomized rats.
    Ito N; Tatematsu M; Hirose M; Nakanishi K; Murasaki G
    Gan; 1978 Feb; 69(1):143-4. PubMed ID: 416986
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of liver regeneration on the loss of fluorenylacetamide derivative bound to liver DNA.
    Witschi H; Epstein SM; Farber E
    Cancer Res; 1971 Mar; 31(3):270-3. PubMed ID: 5547215
    [No Abstract]   [Full Text] [Related]  

  • 23. Nature of early appearing, carcinogen-induced liver lesions to iron accumulation.
    Williams GM; Klaiber M; Parker SE; Farber E
    J Natl Cancer Inst; 1976 Jul; 57(1):157-65. PubMed ID: 1003498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The resistance of putative premalignant liver cell populations, hyperplastic nodules, to the acute cytotoxic effects of some hepatocarcinogens.
    Farber E; Parker S; Gruenstein M
    Cancer Res; 1976 Nov; 36(11 Pt 1):3879-87. PubMed ID: 975037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cellular analysis of liver carcinogenesis. VI. Growth and ultrastructural characteristics of n-2-fluorenylacetamide hyperplastic liver nodule cells grown in vitro.
    Slifkin M; Merkow LP; Epstein SM; Pardo M
    Arch Pathol; 1972 Jul; 94(1):1-10. PubMed ID: 4338214
    [No Abstract]   [Full Text] [Related]  

  • 26. Rapid uptake of dietary cholesterol by hyperplastic liver nodules and primary hepatomas.
    Horton BJ; Mott GE; Pitot HC; Goldarb S
    Cancer Res; 1973 Mar; 33(3):460-4. PubMed ID: 4347713
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of 3-methylcholanthrene on liver carcinogenesis in rats ingesting DL-ethionine, 3'-methyl-4-dimethylaminoazobenzene, and N-2-fluorenylacetamide.
    Marugami M; Ito N; Konishi Y; Hiasa Y; Farber E
    Cancer Res; 1967 Nov; 27(11):2011-9. PubMed ID: 4965303
    [No Abstract]   [Full Text] [Related]  

  • 28. DNA of rat hepatomas: search for gene amplification.
    Shearer RW
    Biochem Biophys Res Commun; 1971 Jun; 43(6):1324-8. PubMed ID: 4328045
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on chromatin. II. Effects of carcinogens and hormones on rat liver chromatin.
    Sporn MB; Dingman CW
    Cancer Res; 1966 Dec; 26(12):2488-95. PubMed ID: 4959456
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of hydroxyurea and 6-mercaptopurine on growth and some aspects of carbohydrate metabolism in regenerating and neoplastic liver.
    Lea MA; Sasovetz D; Musella A; Morris HP
    Cancer Res; 1970 Jul; 30(7):1994-9. PubMed ID: 4318463
    [No Abstract]   [Full Text] [Related]  

  • 31. Reactivities of the carcinogens, N-hydroxy-2-fluorenylacetamide and N-hydroxy-3-fluorenylacetamide, with tissue nucleophiles.
    Zieve FJ; Gutmann HR
    Cancer Res; 1971 Apr; 31(4):471-6. PubMed ID: 5553692
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of the effect of the carcinogen N-hydroxy-N-2-fluorenylacetamide in infant and weanling rats.
    Weisburger JH; Klein M; Weisburger EK; Glass RM; Woodard G; Cronin MT
    J Natl Cancer Inst; 1970 Jul; 45(1):29-35. PubMed ID: 4317737
    [No Abstract]   [Full Text] [Related]  

  • 33. Activation of the carcinogen, N-hydroxy-2-fluorenylbenzene-sulfonamide, by desulfonylation to N-2-fluorenylhydroxylamine in vivo.
    Malejka-Giganti D; Gutmann HR; Rydell RE; Yost Y
    Cancer Res; 1971 Jun; 31(6):778-88. PubMed ID: 4326035
    [No Abstract]   [Full Text] [Related]  

  • 34. A new common marker for premalignant and malignant hepatocytes induced in the rat by chemical carcinogens.
    Okita K; Kligman LH; Farber E
    J Natl Cancer Inst; 1975 Jan; 54(1):199-202. PubMed ID: 163316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of various chemicals on the development of hyperplastic liver nodules in hepatectomized rats treated with N-nitrosodiethylamine or N-2-fluorenylacetamide.
    Ito N; Tatematsu M; Nakanishi K; Hasegawa R; Takano T; Imaida K; Ogiso T
    Gan; 1980 Dec; 71(6):832-42. PubMed ID: 7274629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated concentrations of serum alpha-fetoprotein in rats with chemically induced liver tumors.
    Kroes R; Sontag JM; Sell S; Williams GM; Weisburger JH
    Cancer Res; 1975 May; 35(5):1214-7. PubMed ID: 47266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional markers and growth behavior of preneoplastic hepatocytes.
    Williams GM
    Cancer Res; 1976 Jul; 36(7 PT 2):2540-3. PubMed ID: 58721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and identification of the carcinogen N-hydroxy-2-fluorenylacetamide and related compounds by liquid chromatography.
    Gutmann HR
    Anal Biochem; 1974 Apr; 58(2):469-78. PubMed ID: 4827393
    [No Abstract]   [Full Text] [Related]  

  • 39. Combined enzyme histochemical and radioautographic studies on areas of hyperplasia in the liver of rats fed N-2-fluorenylacetamide.
    Kitagawa T; Sugano H
    Cancer Res; 1973 Nov; 33(11):2993-3001. PubMed ID: 4355988
    [No Abstract]   [Full Text] [Related]  

  • 40. Cytology and cytogenesis of neoplastic (hyperplastic) hepatic nodules.
    Bannasch P
    Cancer Res; 1976 Jul; 36(7 PT 2):2555-62. PubMed ID: 1277165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.